| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | $8.09M | $13.62M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $179.21M | $129.73M | $104.25M | $114.55M | $85.87M |
| R&D | $140.32M | $96.43M | $76.56M | $78.42M | $58.74M |
| SG&A | $38.88M | $33.30M | $27.75M | $28.95M | $27.14M |
| Operating Income | -$179.21M | -$129.73M | -$104.25M | -$106.45M | -$72.25M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$174.32M | -$124.70M | -$96.02M | -$85.98M | -$72.19M |
| EPS (basic) | -1.9900 | -3.0600 | -4.8300 | -10.1000 | -10.1400 |
| EPS (diluted) | -1.9900 | -3.0600 | -4.8300 | -10.1000 | -10.1400 |
| Shares (diluted) | $87.50M | $40.82M | $19.88M | $8.51M | $7.12M |